This review highlights chemerin’s role as a promising target for novel interventions in hypertension, kidney disease, inflammatory disorders, and metabolic syndrome, potentially transforming treatment strategies for these interconnected conditions. The gene discussed is RARRES2; the disease is metabolic syndrome.